Novogen appoints Chartered Director Iain Ross as acting CEO and re-appoints him to the Board Sydney, July 22, 2015 – Novogen Limited (ASX:NRT; NASDAQ: NVGN), a US-Australian drug development company, today announced the appointment to the Board of Iain Ross, an experienced multi-national pharmaceutical and biotechnology executive. Mr Ross, a former director of Novogen Limited will re-join the Board with immediate effect and take on the role of Acting Chief Executive until a permanent appointme.. show all text
posted by friends:
(3)
(3)
@ProfessionalDir: Chartered Director Iain Ross appointed Novogen acting CEO Novogen appoints Chartered Director Iain wp.me/p31IDq-6O #CDir #CorpGov
@CorpTropolis: Chartered Director Iain Ross appointed Novogen acting CEO Novogen appoints Chartered Director Iain wp.me/p31IDq-6O #CDir #CorpGov
@CDir_org: Chartered Director Iain Ross appointed Novogen acting CEO Novogen appoints Chartered Director Iain wp.me/p31IDq-6O #CDir #CorpGov
posted by followers of the list:
(0)
(0)
Vía All News on ‘The Twitter Times: Muzaffar1969/cosec’ http://ift.tt/1JauxOI
No comments:
Post a Comment